I don't think the p 2b will do much to the stock price unless the results are much better than the p 2a 200mg.
That said, I'm buying under a buck again this morning. Got something like 8k free shares out of the last flip. Want to slowly rebuild a position coming into the trial results but am too cheap to spend anything longer-term.
There is an error in the current corporate presentation on page 11. The left side of the chart shows the correct dosing plan of 300mg/placebo/400mg. The right side shows the two test groups at 150mg and 200mg respectively.